Compounds > sch 34343
Page last updated: 2024-08-25

sch 34343 and Bacterial Infections

sch 34343 has been researched along with Bacterial Infections in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alderman, HC; Alvarez, ME; Bodey, GP; Ho, DH; Hoy, JF; Rolston, KV1
Bywater, MJ; Holt, HA; Reeves, DS1
Wells, CL; Wilkins, TD1

Other Studies

3 other study(ies) available for sch 34343 and Bacterial Infections

ArticleYear
In-vitro activity of Sch 34343, a new penam, against gram-positive isolates from cancer patients.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 18, Issue:2

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Gram-Positive Bacteria; Humans; Imipenem; Lactams; Listeria monocytogenes; Neoplasms; Staphylococcus; Streptococcus; Thienamycins

1986
Comparative in-vitro activity of Sch 34343, a new penem antibiotic.
    The Journal of antimicrobial chemotherapy, 1985, Volume: 15 Suppl C

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Stability; Lactams; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Protein Binding; Time Factors

1985
Comparative in-vitro activity of Sch 34343 for a wide spectrum of clinically significant anaerobic bacteria.
    The Journal of antimicrobial chemotherapy, 1985, Volume: 15 Suppl C

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides; Clostridium; Drug Resistance, Microbial; Fusobacterium; Humans; Lactams; Microbial Sensitivity Tests; Peptococcus; Streptococcus

1985